ProPeptide Retatrutide
The first triple-agonist peptide to reach Phase 2 clinical trials. Retatrutide simultaneously activates GLP-1 (satiety), GIP (insulin response), and glucagon (energy expenditure) receptors. Pre-filled FlexiPen with 200 precision clicks at 0.1mg each. Available in Dubai and across the UAE for in-vitro laboratory research.
CAS 2381089-83-2
Janoshik Analytical
200 clicks × 0.1mg
Next-day other emirates
Retatrutide FAQ
What is retatrutide?
Retatrutide (LY3437943) is a novel synthetic triple-agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. It is the first compound to target all three metabolic pathways in a single molecule. In the 48-week Phase 2 trial (n=338), the highest-dose cohort achieved 24.2% mean body weight reduction. CAS: 2381089-83-2.
How does triple agonism differ from semaglutide?
Semaglutide is a single-agonist (GLP-1 only). Tirzepatide is a dual-agonist (GLP-1 + GIP). Retatrutide is the first triple-agonist — activating GLP-1 for satiety signalling, GIP for insulin secretion, and glucagon for hepatic energy expenditure and thermogenesis. This three-pathway approach addresses both energy intake and expenditure simultaneously.
What is the purity?
COA has been submitted to Janoshik Analytical for independent HPLC analysis and identity confirmation. Results will be published on our COA library once testing is complete.
What are the pricing tiers?
AED 1,200 per pen (single), AED 3,300 for a 3-pack (AED 1,100/pen), AED 5,000 for a 5-pack (AED 1,000/pen). Same-day delivery in Dubai for orders placed before 4 PM, next-day across other UAE emirates. Payment and order confirmation via WhatsApp.
How should the pen be stored?
Store at +2 to +8°C (refrigerated). Do not freeze. The FlexiPen is pre-filled — no reconstitution needed. Each pen contains 20mg of retatrutide delivered across 200 precision clicks at 0.1mg per click. Cold-chain delivered to maintain integrity.
What Phase 2 data exists?
The pivotal Phase 2 trial was published in the New England Journal of Medicine (2023). 338 adults with obesity were randomised across multiple dose cohorts over 48 weeks. The highest-dose group achieved 24.2% mean body weight reduction. 100% of participants in that cohort achieved ≥5% weight loss by week 24. Secondary endpoints showed significant reductions in liver fat content and improvements in cardiometabolic markers.
Is retatrutide available in the UAE?
Yes. Retatrutide is available in Dubai and across the UAE for in-vitro laboratory research purposes under UAE MoHAP Circular 17/2022 governing research-use compounds. It is not approved for human consumption, therapeutic use, or veterinary use. See our UAE research peptide compliance guide for full detail.
Order Retatrutide — Dubai & UAE
20mg FlexiPen • COA submitted to Janoshik • From AED 1,000/pen • Same-day Dubai delivery • WhatsApp confirmation in minutes.